Foundation / Corporation
Alzheimer's Drug Discovery Foundation (ADDF)
11/08/19 5:00 PM EST Receipt
Grants to USA, Canada, and International researchers, postdoctoral fellows, and clinicians based at nonprofit organizations, universities, academic medical centers, and biotechnology companies for clinical studies of therapies for Alzheimer’s and related dementias. Applicants must submit an LOI prior to submitting a full application.
The goal of this RFP is to increase the number of innovative pharmacologic interventions tested in clinical studies for Alzheimer's disease and related dementias. The PACT RFP supports clinical trials, experimental medicine, and regulatory studies for novel drugs (small molecules and biologics including antibodies, peptides, gene therapies), repurposed drugs (existing drugs that are approved for other diseases and conditions), repositioned drugs (existing drugs that have entered clinical trials for other indications and have not yet been approved), and natural products.
Specifically, the PACT RFP supports:
Early-stage human clinical trials:
Drug Targets - Current target areas of interest include, but are not limited to:
Other novel targets and pathways that are supported by compelling evidence demonstrating a rational biological connection to the disease process are encouraged.
For information on grant expectations, targets, and clinical trial design, see the URL for Full Text link below.
GrantWatch ID#: 172502
Grants are up to $5 million based on stage and scope of research. Depending on the availability of funds, in certain cases, well-justified larger budgets may be considered.
Average grant duration varies (multi-year) with potential for follow-on funding.
Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.
For program-related inquiries, please contact:
Alessio Travaglia, PhD, Scientific Program Officer
For application submission inquiries, please contact:
Grants and Mission-Related Investments Team
Alzheimer's Drug Discovery Foundation
57 West 57th Street, Suite 904
New York, NY 10019
USA: Alabama; Alaska; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; Florida; Georgia; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hampshire; New Jersey; New Mexico; New York City; New York; North Carolina; North Dakota; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Vermont; Virginia; Washington, DC; Washington; West Virginia; Wisconsin; Wyoming
USA Territories: American Samoa (USA) Guam (USA) Puerto Rico (USA) Virgin Islands (USA) Northern Mariana Islands (USA)
USA Compact Free Associations: The Federated States of Micronesia (USA) Marshall Islands (USA) Republic of Palau (USA)
Canada: Alberta British Columbia Manitoba New Brunswick Newfoundland and Labrador Northwest Territories Nova Scotia Nunavut Ontario Prince Edward Island Quebec Saskatchewan Yukon
International country outside of the USA, Israel and Canada.